China’s mechanical heart valves market to reach $50m in 2033

The country accounts for about 50% of the market share in the Asia Pacific.

China’s mechanical heart valves market is expected to hit $50m in 2033 amidst an increasing incidence of cardiovascular diseases and rising demand for surgeries, according to GlobalData.

The country was identified as the largest market in the Asia Pacific region, accounting for approximately half of the market share.

One notable development is the partnership between Peijia Medical Technology (Suzhou) Co Ltd and DSM-Firmenich for the joint research and development of polymer heart valves.

“The new polymer-based valve designs represent a significant advancement over traditional mechanical valves, which typically necessitate lifelong anticoagulation therapy and may not be suitable for minimally invasive procedures,” said Divya Soni, Medical Devices Analyst at GlobalData.

“Such characteristics are anticipated to expand treatment options, especially for younger or more active patients,” Soni added.